(Press-News.org) Geneva, Switzerland, 17 April 2015 -- A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma, the authors of a new academic clinical trial in Europe have reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland.
Dr. Oliver Gautschi, a medical oncologist from Lucern Cantonal Hospital in Switzerland, presented the results of the retrospective EURAF cohort study, which included lung cancer patients whose tumours carried specific mutations in the BRAF gene. The study was conducted by a network of European oncologists, without company involvement.
BRAF mutations are commonly seen in melanoma patients, and are found in about 2% of lung adenocarcinomas, Gautschi explains. Several inhibitors of the B-Raf protein, including vemurafenib and dabrafenib, have been developed for use in melanoma patients, however there is currently no approved drug for BRAF-mutant lung cancer.
As a result, experience with B-Raf inhibitors in lung cancer remains limited. "In the current study, we wanted to find out how many patients in Europe received B-Raf inhibitors outside of a clinical trial, and what their outcomes were," Gautschi says.
The EURAF study gathered information on 35 lung cancer patients who had been identified as carrying BRAF mutations, who were treated with B-Raf inhibitors between 2012 and 2014.
Most of those patients received vemurafenib, some dabrafenib, and one sorafenib. Overall response rate was 53% as measured by the widely used Response Evaluation Criteria In Solid Tumors (RECIST) guidelines. Overall, progression-free survival time in this group was 5 months.
Most patients were pretreated, and not eligible for enrolment in a clinical trial, which means these results are encouraging, the researchers say, although the study's small size and retrospective nature mean the analysis of the magnitude of benefit should be treated cautiously.
"The bottom line is that clinicians should be sure to test patients for so-called 'rare' driver mutations in lung cancer, because individual patients may derive substantial benefit from targeted therapy," says Gautschi.
Commenting on the findings, Dr David Planchard, pulmonary oncologist at Gustave Roussy in Villejuif, France, said that the results of the trial confirm the benefit of B-Raf inhibitors in BRAF-mutant non-small cell lung cancer. The current trial also confirmed the good tolerance of the drugs with no new side-effects, he said. Planchard and colleagues have presented a separate phase II study in this area with dabrafenib [1].
"This trial is important because due to the low frequency of this mutation in non-small cell lung cancer we will have few trials on this population," Planchard commented. "The more data we have, the better we understand how important it is to test for the mutation, especially in adenocarcinomas, and to expose mutation-positive patients to a specific B-Raf inhibitor."
The results also add to growing support for the approval of B-Raf inhibitors for use in lung cancer, Planchard added. This is important because the rarity of this mutation means that performing the kind of randomized phase III trials usually required for licensing approval will be extremely difficult, he noted.
Looking ahead, it will also be important to see results of combination therapy with inhibitors of B-Raf and a related protein, Mek, in non-small cell lung cancer carrying BRAF-V600E mutations, the researchers note, as this combination has shown a higher clinical benefit in BRAF-mutant melanoma.
INFORMATION:
Many professional golfers live a lonely isolated life in the midst of intense rivalries and on a meagre income, new research shows.
Dr John Fry told the British Sociological Association's annual conference in Glasgow today [Friday 17 April] that he interviewed 20 professionals, including Ryder Cup players and a former world number one, to reveal the "particular stresses" behind the glamour of the game.
Dr Fry, of Myerscough College, said that the number of tournaments held abroad had increased over recent years. "The impact of the increasingly global nature of professional ...
Demand for natural rubber fuelled by the tyre industry is threatening protected parts of Southeast Asia - according to research from the University of East Anglia (UEA).
A new study published today predicts that up to 8.5 million hectares of additional rubber plantations will be required to meet demand by 2024.
But expansion on this scale will have 'catastrophic' biodiversity impacts, with globally threatened unique species and ecosystems all put under threat.
Researchers say that the extent of the problem is comparable to oil palm and that it is closely linked ...
The 9/11 attacks on the World Trade Center in New York City in 2001 have left a legacy of chronic ill health among emergency medical services workers who came to the rescue of the victims, reveals research published online in Occupational & Environmental Medicine.
Those who arrived in the immediate aftermath of the attacks are most at risk of physical and mental ailments, the findings show.
The health of 2281 New York City Fire Department emergency medical services workers deployed to the scene of the World Trade Center attacks was tracked over a period of 12 years, ...
(Boston)--A Boston researcher and physician caring for individuals with substance abuse disorders, believes the term opioid substitution therapy (OST) has unintended adverse consequences for patients receiving treatment for addiction.
In a correspondence to the editors of the journal Lancet, Jeffrey H. Samet, MD, MA, MPH, professor of medicine at Boston University School of Medicine (BUSM) and chief of the section of General Internal Medicine at Boston Medical Center maintains that the use of the non-medical term OST serves to reinforce the concept that this type of treatment ...
The Lancet Neurology journal is pleased to announce that the following papers will be published as part of a Series on autism spectrum disorder, ahead of the 2015 Annual Meeting of the American Academy of Neurology:
Gene hunting in autism spectrum disorder: on the path to precision medicine [Embargo: 6:30pm [New York time] Thursday 16 April, 2015]
Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan [Embargo: 6:30pm [New York time] Thursday 16 April, 2015]
Gene hunting in autism spectrum disorder: on the path to precision medicine ...
Highlights
Among dialysis patients, genetically related family members have about a 70% increased risk of cardiac arrest compared with unrelated dialysis patients.
Spouses on dialysis do not have an increased risk.
Cardiac arrest is the #1 cause of death in patients on dialysis.
Washington, DC (April 16, 2015) -- The increased risk of cardiac arrest experienced by patients with kidney failure may, in part, be inherited, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Uncovering the genes that are ...
A new study has found that wind instrument players have a reduced risk of developing obstructive sleep apnoea.
The findings, presented today (17 April 2015) at the Sleep and Breathing Conference 2015, suggest that this could be considered beneficial to those individuals who are at high risk of developing sleep apnoea.
Researchers in India conducted lung function testing in 64 people who played a wind instrument and compared results to a control group of 65 people who did not play any wind instruments. All participants also completed the Berlin questionnaire, an established ...
Cancer-related post-traumatic stress is associated with very limited cognitive impairment before treatment among newly diagnosed breast cancer patients, according to a new study published April 16 in the JNCI: Journal of the National Cancer Institute.
Pretreatment cognitive impairment and symptoms of post-traumatic stress disorder have been independently reported among cancer patients. Post-traumatic stress has also been linked to cognitive impairment. However, a clear relationship between post-traumatic stress in the setting of a cancer diagnosis and cognitive impairment ...
WASHINGTON, DC - A drug commonly taken to prevent seizures in epilepsy may surprisingly protect the eyesight of people with multiple sclerosis (MS), according to a study released today that will be presented at the American Academy of Neurology's 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.
"About half of people with MS experience at some point in their life a condition called acute optic neuritis, in which the nerve carrying vision from the eye to the brain gets inflamed," said study author Raj Kapoor, MD, with the National Hospital for Neurology and ...
The rapid increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation tool. A study, published online on April 16 in the American Journal of Public Health, suggests proponents are in error.
University of California, San Diego School of Medicine researchers found that smokers who used e-cigarettes were 49 percent less likely to decrease cigarette use and 59 percent less likely to quit smoking compared to smokers who never used e-cigarettes. ...
